Lipotris™

  • Lipotris™ 1
  • Lipotris™ 2
  • Lipotris™ 3
Product Description

Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfaces, due to interaction between lubricin and liposomes enveloped with HA chains in the form of intra-articular gel. 

Read more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
View company profile
Categories
more categories Show less
Specifications
  • Details
    Lipotris™ is a liposomal composite gel formed with a 44mg sodium hyaluronate and 1.6mg liposomes provided in a the injection of 2ml. The highly concentrated hyaluronic acid contained in Lipotris™ has precisely tailored physicochemical parameters, including an optimally high molecular weight. Additionally, Lipotris™ composite gel contains synthetic liposomes, created from phospholipids (1-palmitoyl-2-oleoyl-phosphatidylcholine, POPC) that have a strictly defined size.Dedicated to knees and other synovial joints.
  • Selling Points
    Bone & Joint Health; Brand Name; Lipotris™ is a composite of hyaluronic acid and liposomes that form a consolidated material.Upon intra-articular injection, Lipotris™ actively interacts with lubricin.Mentioned interaction transforms the motion in the joint from sliding to rolling, providing a surface with negligible friction, providing the correct, high-quality joint movement. For this reason, Lipotris™ therapy is able to provide an exceptionally rapid and long-lasting clinical response.Only three injections to achieve therapeutic effect.Provides immediate pain reliefand noticeable improvement inmobility. Proven to help patients with moderate to advanced osteoarthritis (grades II and III). Clinically proven to reduces joint pain andimproved OA patients quality of life.
  • Supplied from
    Poland
More specifications Fewer specifications

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
View company profile

More Products from Biovico Sp. z o.o. (19)

  • Chondrovox™ bis

    Product Chondrovox™ bis

    Chondrovox™ is based on chondroitin sulfate, which occurs naturally in articular cartilage. In combination with proteins creates proteoglycans responsible for proper flexibility and mechanical properties of cartilage. Produced in accordance with strict rules of European Pharmacopoeia standards.
  • DKK DERM™ procedure kit

    Product DKK DERM™ procedure kit

    DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
  • AOORA™

    Product AOORA™

    Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin.
  • Flavya™ Post Treatment Occlusive Face Mask

    Product Flavya™ Post Treatment Occlusive Face Mask

    Flavya™ Post Treatment Occlusive Face Mask is a medical device in the form of a biocellulose mask soaked in hyaluronic acid. Thanks to its occlusive properties, the mask creates a protective barrier on the skin, which is particularly important after medical esthetic  treatments. Additionally, ...
  • Flavya™ Post Treatment Occlusive Patch

    Product Flavya™ Post Treatment Occlusive Patch

    Flavya™ Post Treatment Occlusive Patch is a medical device in the form of a biocellulose dressing soaked in hyaluronic acid, available in two sizes:
    • 10 × 10 cm • 10 × 20 cm. It is intended for use on specific areas of the body, such as the neck, décolletage, perioral area, and ha...
  • Biolevox™ HA

    Product Biolevox™ HA

    The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.
    • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom ...
  • Xerthra™ kits

    Product Xerthra™ kits

    Xerthra™ PRP kit is a new generation, high-performance platelet (PLT) separation device, dedicated to preparation of platelet-rich plasma (PRP) from patient’s blood. Large number of growth factors released from PLTs delivered by PRP will lead to improvement of regenerative properties of patient’s cell...
  • Wint™ kit

    Product Wint™ kit

    Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
  • FLAVYA™

    Product FLAVYA™

    Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.

  • Biolevox™ HA 2.2%

    Product Biolevox™ HA 2.2%

    Biolevox™ HA 2.2% is a hyaluronic acid (HA) gel designed for a three intra-articular injection into the osteoarthritis (OA) affected in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint. Designed HA-based gel contains 44 mg of hyaluronate in 2 ml pre-filled syringe. The co...
  • Biolevox™ HA mini

    Product Biolevox™ HA mini

    Biolevox™ HA MINI is a hyaluronic acid (HA) gel dedicated to the intra-articular injection into the small synovial joints effected by the osteoarthritis (OA) disease. Specified HA-based gel contains 16 mg of sodium hyaluronate in 1 ml pre-filled syringe. Biolevox™ HA MINI is intended for intra-ar...
  • Biolevox™ HA tendon

    Product Biolevox™ HA tendon

    Biolevox™ HA Tendon is hyaluronic acid (HA) gel especially designed for intratendinous or peritendinous injection as a double application therapy in order to alleviate the ongoing inflammation process and further recovery of the tendon functionality. HA-based gel contains 32 mg of sodium hyaluronate in 2.0...
show all 19 other products

Biovico Sp. z o.o. resources (4)